Roche forecast another year of market beating growth based on continuing strong demand for its breakthrough cancer drugs and other new products.

Franz Humer, chairman and chief executive of the Swiss pharmaceuticals and diagnostics group, said on Wednesday he expected sales to grow in high single digits this year, prompting another record for revenues and profits.